Adagene and Exelixis Advance SAFEbody ADC Programs
San Diego, California, USA, and Suzhou, China, September 9, 2026 Adagene Inc. and Exelixis Inc. have achieved a new...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
San Diego, California, USA, and Suzhou, China, September 9, 2026 Adagene Inc. and Exelixis Inc. have achieved a new...
San Francisco, California, USA, September 9, 2026 Eir Partners has acquired Accumulus Technologies, marking a new phase of growth...
Solana Beach, California | January 22, 2026 ClearPoint Neuro has announced the successful EU Medical Device Regulation (EU MDR)...
FRANKLIN LAKES, New Jersey | January 19, 2026 — Becton, Dickinson and Company (BD) announced that the U.S. Food...
PHOENIX | January 6, 2026 — Sunbelt Bakery has unveiled a new packaging design for its consumer snack products,...
SAN FRANCISCO & BOSTON | January 6, 2026 — Apogee Therapeutics has reported positive interim results from a Phase...
IRVING, Texas | January 6, 2026 — Vizient, Inc. has released a new analysis showing early and uneven shifts...
FLAGSTAFF, Arizona | January 6, 2026 — W. L. Gore & Associates has secured U.S. FDA approval for the...
REYKJAVÍK, ICELAND | December 31, 2025 — Alvotech announced it has secured a USD 100 million senior term loan...
December 22, 2025 | Foster City, California — Gilead Sciences announced a three-year agreement with the U.S. Government designed...
